Lynn Morris

30PUBLICATIONS
177CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Genetic immunologyInnate immunityNanotoxicology, health and safetyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Sep 08, 2026
VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Jan 19, 2024
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.

Michal Juraska, Hongjun Bai, Allan C deCamp

|Dec 14, 2023
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.

Daniel B Reeves, Bryan T Mayer, Allan C deCamp

|Jun 29, 2023
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.

Nonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine

|Aug 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.

Peter B Gilbert, Yunda Huang, Allan C deCamp

Pageof 5

Frequent Collaborators

9 joint publications

Penny L Moore

8 joint publications

David Montefiori

8 joint publications

Peter B Gilbert

6 joint publications

Paul T Edlefsen